Last Updated: September 28, 2026

Litigation Details for TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)

✉ Email this page to a colleague

« Back to Dashboard

TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)

Docket	3:19-cv-01028-FLW-LHG	Date Filed	2019-01-23
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Freda L. Wolfson
Jury Demand	None	Referred To
Patents	7,560,445; 7,977,324
Link to Docket	External link to docket

Small Molecule Drugs cited in TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC

The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .

Details for TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2019-01-23	63	Opinion	are four patents owned by Taro which share a common specification: U.S. Patent Nos. 7,560,445 (“the ’455… 1 patent”), and 8,536,155 (“the ’155 patent”) (collectively, the “patents-in-suit”). Pls.…53 of the ’445 patent, Claims 20, and 31 of the ’324 patent, Claim 28 of the ’657 patent, and Claim 18…’455 patent”), 7,977,324 (“the ’324 patent”), 8,039,657 (“the ’657 …445 Patent at 2:58-3:3. Taro currently markets formulations utilizing embodiments of the patents-in-suit	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.